Sawtooth Solutions LLC raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 6.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,435 shares of the medical research company’s stock after acquiring an additional 87 shares during the quarter. Sawtooth Solutions LLC’s holdings in Thermo Fisher Scientific were worth $393,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in TMO. Oregon Public Employees Retirement Fund boosted its position in shares of Thermo Fisher Scientific by 44,296.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 19,565,960 shares of the medical research company’s stock worth $87,000 after acquiring an additional 19,521,889 shares in the last quarter. Norges Bank acquired a new position in shares of Thermo Fisher Scientific during the 4th quarter worth about $946,280,000. FMR LLC boosted its position in shares of Thermo Fisher Scientific by 33.4% during the 4th quarter. FMR LLC now owns 8,671,713 shares of the medical research company’s stock worth $1,940,642,000 after acquiring an additional 2,172,574 shares in the last quarter. BlackRock Inc. boosted its position in shares of Thermo Fisher Scientific by 4.1% during the 1st quarter. BlackRock Inc. now owns 27,251,678 shares of the medical research company’s stock worth $7,459,327,000 after acquiring an additional 1,074,400 shares in the last quarter. Finally, Cantillon Capital Management LLC boosted its position in shares of Thermo Fisher Scientific by 91.3% during the 4th quarter. Cantillon Capital Management LLC now owns 1,024,930 shares of the medical research company’s stock worth $229,369,000 after acquiring an additional 489,081 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Several research analysts have recently issued reports on TMO shares. Bank of America reaffirmed a “buy” rating and set a $300.00 price objective (up from $285.00) on shares of Thermo Fisher Scientific in a research report on Tuesday, April 16th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $312.00 price objective for the company in a research report on Wednesday, May 8th. BTIG Research upped their price objective on Thermo Fisher Scientific to $320.00 and gave the stock a “buy” rating in a research report on Thursday, May 23rd. Barclays upped their target price on Thermo Fisher Scientific from $295.00 to $300.00 and gave the company an “overweight” rating in a research report on Monday, March 18th. Finally, Needham & Company LLC reissued a “strong-buy” rating and issued a $315.00 target price (up from $313.00) on shares of Thermo Fisher Scientific in a research report on Thursday, May 23rd. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $295.92.
Shares of NYSE TMO opened at $285.26 on Friday. The stock has a market capitalization of $114.49 billion, a P/E ratio of 25.04, a PEG ratio of 1.88 and a beta of 1.08. The company has a quick ratio of 1.16, a current ratio of 1.69 and a debt-to-equity ratio of 0.61. Thermo Fisher Scientific Inc. has a 52-week low of $202.83 and a 52-week high of $288.07.
Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, April 24th. The medical research company reported $2.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.74 by $0.07. The firm had revenue of $6.13 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Thermo Fisher Scientific had a return on equity of 17.06% and a net margin of 12.89%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.50 EPS. As a group, research analysts forecast that Thermo Fisher Scientific Inc. will post 12.2 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 16th. Shareholders of record on Friday, June 14th will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.27%. The ex-dividend date of this dividend is Thursday, June 13th. Thermo Fisher Scientific’s dividend payout ratio is presently 6.83%.
ILLEGAL ACTIVITY NOTICE: “Sawtooth Solutions LLC Has $393,000 Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4372447/sawtooth-solutions-llc-has-393000-stake-in-thermo-fisher-scientific-inc-nysetmo.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Further Reading: Is it Safe to Invest in Commodities?
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.